Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis

Authors: Leonam G Coutinho, Denis Grandgirard, Stephen L Leib, Lucymara F Agnez-Lima

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Bacterial meningitis is characterized by an intense inflammatory reaction contributing to neuronal damage. The aim of this study was to obtain a comparative analysis of cytokines and chemokines in patients with pneumococcal (PM) and meningococcal meningitis (MM) considering that a clear difference between the immune response induced by these pathogens remains unclear.

Methods

The cyto/chemokines, IL-1β, IL-2, IL-6, TNF-α, IFN-γ, IL-10, IL-1Ra, CXCL8/IL-8, CCL2/MCP-1, CLL3/MIP-1α, CCL4/MIP-1γ and G-CSF, were measured in cerebrospinal fluid (CSF) samples from patients with PM and MM. Additionally, a literature review about the expression of cytokines in CSF samples of patients with MB was made.

Results

Concerning cytokines levels, only IFN-γ was significantly higher in patients with Streptococcus pneumoniae compared to those with Neisseria meningitidis, regardless of the time when the lumbar puncture (LP) was made. Furthermore, when samples were compared considering the timing of the LP, higher levels of TNF-α (P <0.05) were observed in MM patients whose LP was made within 48 h from the initial symptoms of disease. We also observed that the index of release of cyto/chemokines per cell was significantly higher in PM. From the literature review, it was observed that TNF-α, IL-1β and IL-6 are the best studied cytokines, while reports describing the concentration of the cytokine IL-2, IL-1Ra, G-CSF and CCL4/MIP-1β in CSF samples of patients with bacterial meningitis were not found.

Conclusion

The data obtained in this study and the previously published data show a similar profile of cytokine expression during PM and MM. Nevertheless, the high levels of IFN-γ and the ability to release high levels of cytokines with a low number of cells are important factors to be considered in the pathogenesis of PM and thereby should be further investigated. Moreover, differences in the early response induced by the pathogens were observed. However, the differences observed are not sufficient to trigger changes in the current therapy of corticosteroids adopted in both the PM and MM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA: Bacterial meningitis in the United States in 1995. N Engl J Med. 1997, 337: 970-9762.CrossRefPubMed Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA: Bacterial meningitis in the United States in 1995. N Engl J Med. 1997, 337: 970-9762.CrossRefPubMed
2.
go back to reference Silva WA, Pinheiro AM, Coutinho LG, Marinho LA, Lima LF: Epidemiological profile of acute bacterial meningitis in the state of Rio Grande do Norte, Brazil. Rev Soc Bras Med Trop. 2010, 43: 455-457.CrossRefPubMed Silva WA, Pinheiro AM, Coutinho LG, Marinho LA, Lima LF: Epidemiological profile of acute bacterial meningitis in the state of Rio Grande do Norte, Brazil. Rev Soc Bras Med Trop. 2010, 43: 455-457.CrossRefPubMed
3.
go back to reference Novaes HM, Sartori AM, Soárez PC: Hospitalization rates for pneumococcal disease in Brazil, 2004–2006. Rev Saude Publica. 2011, 45: 539-547.CrossRefPubMed Novaes HM, Sartori AM, Soárez PC: Hospitalization rates for pneumococcal disease in Brazil, 2004–2006. Rev Saude Publica. 2011, 45: 539-547.CrossRefPubMed
4.
go back to reference Sáfadi MA, Cintra OA: Epidemiology of meningococcal disease in Latin America, current situation and opportunities for prevention. Neurol Res. 2010, 32: 263-271.CrossRefPubMed Sáfadi MA, Cintra OA: Epidemiology of meningococcal disease in Latin America, current situation and opportunities for prevention. Neurol Res. 2010, 32: 263-271.CrossRefPubMed
5.
go back to reference Tauber MG, Moser B: Cytokines and chemokines in meningeal inflammation, biology and clinical implications. Clin Infect Dis. 1999, 28: 1-11.CrossRefPubMed Tauber MG, Moser B: Cytokines and chemokines in meningeal inflammation, biology and clinical implications. Clin Infect Dis. 1999, 28: 1-11.CrossRefPubMed
6.
go back to reference van Furth AM, Roord JJ, van Furth R: Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. InfectImmun. 1996, 64: 4883-4890. van Furth AM, Roord JJ, van Furth R: Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. InfectImmun. 1996, 64: 4883-4890.
7.
go back to reference Brandt CT, Caye-Thomasen P, Lund SP, Worsoe L, Ostergaard C, Frimodt-Moller N, Espersen F, Thomsen J, Lundgren JD: Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis. 2006, 23: 300-311.CrossRefPubMed Brandt CT, Caye-Thomasen P, Lund SP, Worsoe L, Ostergaard C, Frimodt-Moller N, Espersen F, Thomsen J, Lundgren JD: Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis. 2006, 23: 300-311.CrossRefPubMed
8.
go back to reference Haberl RL, Anneser F, Kodel U, Pfister HW: Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?. NeurolRes. 1994, 16: 108-112. Haberl RL, Anneser F, Kodel U, Pfister HW: Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?. NeurolRes. 1994, 16: 108-112.
9.
go back to reference Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Hollander GA: Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis, association with blood–brain barrier damage and neurological sequelae. ClinInfect Dis. 2000, 31: 80-84. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Hollander GA: Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis, association with blood–brain barrier damage and neurological sequelae. ClinInfect Dis. 2000, 31: 80-84.
10.
go back to reference Zwijnenburg PJ, de Bie HM, Roord JJ, van der Poll T, van Furth AM: Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. J Neuroimmunol. 2003, 145: 148-153.CrossRefPubMed Zwijnenburg PJ, de Bie HM, Roord JJ, van der Poll T, van Furth AM: Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. J Neuroimmunol. 2003, 145: 148-153.CrossRefPubMed
11.
go back to reference Azuma H, Tsuda N, Sasaki K, Okuno A: Clinical significance of cytokine measurement for detection of meningitis. J Pediatr. 1997, 131: 463-465.CrossRefPubMed Azuma H, Tsuda N, Sasaki K, Okuno A: Clinical significance of cytokine measurement for detection of meningitis. J Pediatr. 1997, 131: 463-465.CrossRefPubMed
12.
go back to reference Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ: Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis. 2008, 198: 1028-1036.CrossRefPubMed Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ: Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis. 2008, 198: 1028-1036.CrossRefPubMed
13.
go back to reference Mogensen TH, Paludan SR, Kilian M, Ostergaard L: Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukocyte Biol. 2006, 80: 267-277.CrossRefPubMed Mogensen TH, Paludan SR, Kilian M, Ostergaard L: Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J Leukocyte Biol. 2006, 80: 267-277.CrossRefPubMed
14.
go back to reference Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, Spreer A, Bunkowski S, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R: Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun. 2010, 78: 865-871.CrossRefPubMed Ribes S, Ebert S, Regen T, Agarwal A, Tauber SC, Czesnik D, Spreer A, Bunkowski S, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R: Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia. Infect Immun. 2010, 78: 865-871.CrossRefPubMed
15.
go back to reference Sjolinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR: Important role for Toll-like receptor 9 in host defense against meningococcal sepsis. InfectImmun. 2008, 76: 5421-5428. Sjolinder H, Mogensen TH, Kilian M, Jonsson AB, Paludan SR: Important role for Toll-like receptor 9 in host defense against meningococcal sepsis. InfectImmun. 2008, 76: 5421-5428.
16.
go back to reference Kastenbauer S, Koedel U, Becker BF, Pfister HW: Oxidative stress in bacterial meningitis in humans. Neurology. 2002, 58: 186-191.CrossRefPubMed Kastenbauer S, Koedel U, Becker BF, Pfister HW: Oxidative stress in bacterial meningitis in humans. Neurology. 2002, 58: 186-191.CrossRefPubMed
17.
go back to reference Mastroianni CM, Lancella L, Mengoni F, Lichtner M, Santopadre P, D’Agostino C, Ticca F, Vullo V: Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin Exp Immunol. 1998, 114: 210-214.CrossRefPubMedPubMedCentral Mastroianni CM, Lancella L, Mengoni F, Lichtner M, Santopadre P, D’Agostino C, Ticca F, Vullo V: Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin Exp Immunol. 1998, 114: 210-214.CrossRefPubMedPubMedCentral
18.
go back to reference de Jonge RC, van Furth AM, Wassenaar M, Gemke RJ, Terwee CB: Predicting sequelae and death after bacterial meningitis in childhood, a systematic review of prognostic studies. BMC Infect Dis. 2010, 10: 232-CrossRefPubMedPubMedCentral de Jonge RC, van Furth AM, Wassenaar M, Gemke RJ, Terwee CB: Predicting sequelae and death after bacterial meningitis in childhood, a systematic review of prognostic studies. BMC Infect Dis. 2010, 10: 232-CrossRefPubMedPubMedCentral
19.
go back to reference Worsøe L, Cayé-Thomasen P, Brandt CT, Thomsen J, Østergaard C: Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis. 2010, 51: 917-924.CrossRefPubMed Worsøe L, Cayé-Thomasen P, Brandt CT, Thomsen J, Østergaard C: Factors associated with the occurrence of hearing loss after pneumococcal meningitis. Clin Infect Dis. 2010, 51: 917-924.CrossRefPubMed
20.
go back to reference Borchorst S, Møller K: The role of dexamethasone in the treatment of bacterial meningitis - a systematic review. Acta Anaesthesiol Scand. 2012, 56: 1210-1221.CrossRefPubMed Borchorst S, Møller K: The role of dexamethasone in the treatment of bacterial meningitis - a systematic review. Acta Anaesthesiol Scand. 2012, 56: 1210-1221.CrossRefPubMed
21.
go back to reference Dulkerian SJ, Kilpatrick L, Costarino AT, McCawley L, Fein J, Corcoran L, Zirin S, Harris MC: Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr. 1995, 126: 872-876.CrossRefPubMed Dulkerian SJ, Kilpatrick L, Costarino AT, McCawley L, Fein J, Corcoran L, Zirin S, Harris MC: Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr. 1995, 126: 872-876.CrossRefPubMed
22.
go back to reference Glimaker M, Kragsbjerg P, Forsgren M, Olcen P: Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies, high levels of TNF alpha indicate bacterial meningitis. J Infect Dis. 1993, 167: 882-889.CrossRefPubMed Glimaker M, Kragsbjerg P, Forsgren M, Olcen P: Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies, high levels of TNF alpha indicate bacterial meningitis. J Infect Dis. 1993, 167: 882-889.CrossRefPubMed
23.
go back to reference Kornelisse RF, Hack CE, Savelkoul HF, van der Pouw Kraan TC, Hop WC, van Mierlo G, Suur MH, Neijens HJ, de Groot R: Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun. 1997, 65: 877-881.PubMedPubMedCentral Kornelisse RF, Hack CE, Savelkoul HF, van der Pouw Kraan TC, Hop WC, van Mierlo G, Suur MH, Neijens HJ, de Groot R: Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun. 1997, 65: 877-881.PubMedPubMedCentral
24.
go back to reference Mukai AO, Krebs VL, Bertoli CJ, Okay TS: TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol. 2006, 34: 25-29.CrossRefPubMed Mukai AO, Krebs VL, Bertoli CJ, Okay TS: TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol. 2006, 34: 25-29.CrossRefPubMed
25.
go back to reference Ohga S, Aoki T, Okada K, Akeda H, Fujioka K, Ohshima A, Mori T, Minamishima I, Ueda K: Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child. 1994, 70: 123-125.CrossRefPubMedPubMedCentral Ohga S, Aoki T, Okada K, Akeda H, Fujioka K, Ohshima A, Mori T, Minamishima I, Ueda K: Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child. 1994, 70: 123-125.CrossRefPubMedPubMedCentral
26.
go back to reference Sharief MK, Ciardi M, Thompson EJ: Blood–brain barrier damage in patients with bacterial meningitis, association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis. 1992, 166: 350-358.CrossRefPubMed Sharief MK, Ciardi M, Thompson EJ: Blood–brain barrier damage in patients with bacterial meningitis, association with tumor necrosis factor-alpha but not interleukin-1 beta. J Infect Dis. 1992, 166: 350-358.CrossRefPubMed
27.
go back to reference Akalin H, Akdis AC, Mistik R, Helvaci S, Kilicturgay K: Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis. 1994, 26: 667-674.CrossRefPubMed Akalin H, Akdis AC, Mistik R, Helvaci S, Kilicturgay K: Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis. 1994, 26: 667-674.CrossRefPubMed
28.
go back to reference Friedland JS, Shattock R, Remick DG, Griffin GE: Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol. 1993, 91: 58-62.CrossRefPubMedPubMedCentral Friedland JS, Shattock R, Remick DG, Griffin GE: Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol. 1993, 91: 58-62.CrossRefPubMedPubMedCentral
29.
go back to reference van Deuren M, Netea MG, Hijmans A, Demacker PN, Neeleman C, Sauerwein RW, Bartelink AK, van der Meer JW: Posttranscriptional down-regulation of tumour necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections. J Infect Dis. 1998, 177: 1401-1405.CrossRefPubMed van Deuren M, Netea MG, Hijmans A, Demacker PN, Neeleman C, Sauerwein RW, Bartelink AK, van der Meer JW: Posttranscriptional down-regulation of tumour necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections. J Infect Dis. 1998, 177: 1401-1405.CrossRefPubMed
30.
go back to reference Marzouk O: Clinical and laboratory aspects of meningococcal disease in childhood. 1994, MD Thesis: Liverpool University Marzouk O: Clinical and laboratory aspects of meningococcal disease in childhood. 1994, MD Thesis: Liverpool University
31.
go back to reference van Deuren M, van der Ven-Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JW: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis. 1994, 169: 157-161.CrossRefPubMed van Deuren M, van der Ven-Jongekrijg J, Demacker PN, Bartelink AK, van Dalen R, Sauerwein RW, Gallati H, Vannice JL, van der Meer JW: Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis. 1994, 169: 157-161.CrossRefPubMed
32.
33.
go back to reference Davenport V, Groves E, Hobbs CG, Williams NA, Heyderman RS: Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa. Cell Microbiol. 2007, 9: 1050-1061.CrossRefPubMed Davenport V, Groves E, Hobbs CG, Williams NA, Heyderman RS: Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa. Cell Microbiol. 2007, 9: 1050-1061.CrossRefPubMed
34.
go back to reference Holub M, Scheinostova M, Dzupova O, Fiserova A, Beran O, Kalmusova J, Musilek M, Krizova P: Neisseria meningitidis strains from patients with invasive meningococcal disease differ in stimulation of cytokine production. Folia Microbiol. 2007, 52: 525-528.CrossRef Holub M, Scheinostova M, Dzupova O, Fiserova A, Beran O, Kalmusova J, Musilek M, Krizova P: Neisseria meningitidis strains from patients with invasive meningococcal disease differ in stimulation of cytokine production. Folia Microbiol. 2007, 52: 525-528.CrossRef
35.
go back to reference Hessle C, Andersson B, WoldA E: Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000, 68: 3581-3586.CrossRefPubMedPubMedCentral Hessle C, Andersson B, WoldA E: Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000, 68: 3581-3586.CrossRefPubMedPubMedCentral
36.
go back to reference Borish LC, Steinke JW: 2. Cytokines and chemokines. J Allerg ClinImmun. 2003, 111: S460-S475.CrossRef Borish LC, Steinke JW: 2. Cytokines and chemokines. J Allerg ClinImmun. 2003, 111: S460-S475.CrossRef
37.
go back to reference D’Elios MM, Benagiano M, Della Bella C, Amedei A: T-cell response to bacterial agents. J Infect Dev C tries. 2011, 5: 640-645. D’Elios MM, Benagiano M, Della Bella C, Amedei A: T-cell response to bacterial agents. J Infect Dev C tries. 2011, 5: 640-645.
38.
go back to reference Olliver M, Hiew J, Mellroth P, Henriques-Normark B, Bergman P: Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect Immun. 2011, 79: 4210-4217.CrossRefPubMedPubMedCentral Olliver M, Hiew J, Mellroth P, Henriques-Normark B, Bergman P: Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect Immun. 2011, 79: 4210-4217.CrossRefPubMedPubMedCentral
40.
go back to reference Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK: Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosc. 2002, 16: 2113-2122.CrossRef Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK: Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur J Neurosc. 2002, 16: 2113-2122.CrossRef
41.
go back to reference Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P: Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep. 2010, 12: 71-76.CrossRefPubMedPubMedCentral Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P: Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep. 2010, 12: 71-76.CrossRefPubMedPubMedCentral
42.
go back to reference Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, Banda DL, Jeffers G, White SA, Molyneux EM, Molyneux ME, Smyth RL, Hart CA: High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007, 26: 416-422.CrossRefPubMedPubMedCentral Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, Banda DL, Jeffers G, White SA, Molyneux EM, Molyneux ME, Smyth RL, Hart CA: High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J. 2007, 26: 416-422.CrossRefPubMedPubMedCentral
43.
go back to reference Dumont RA, Car BD, Voitenok NN, Junker U, Moser B, Zak O, O’Reilly T: Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect Immun. 2000, 68: 5756-5763.CrossRefPubMedPubMedCentral Dumont RA, Car BD, Voitenok NN, Junker U, Moser B, Zak O, O’Reilly T: Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect Immun. 2000, 68: 5756-5763.CrossRefPubMedPubMedCentral
44.
go back to reference Ostergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Moller N, Espersen F, Kharazmi A, Lundgren JD: Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol. 2000, 122: 207-211.CrossRefPubMedPubMedCentral Ostergaard C, Yieng-Kow RV, Larsen CG, Mukaida N, Matsushima K, Benfield T, Frimodt-Moller N, Espersen F, Kharazmi A, Lundgren JD: Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin Exp Immunol. 2000, 122: 207-211.CrossRefPubMedPubMedCentral
45.
go back to reference Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquist L, Wretlind B, Bakhiet M, Link H: Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun. 1999, 67: 2590-2601.PubMedPubMedCentral Diab A, Abdalla H, Li HL, Shi FD, Zhu J, Hojberg B, Lindquist L, Wretlind B, Bakhiet M, Link H: Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun. 1999, 67: 2590-2601.PubMedPubMedCentral
46.
go back to reference van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, Thwaites GE, Tuan PQ, Zwinderman AH: Adjunctive dexamethasone in bacterial meningitis, a meta-analysis of individual patient data. Lancet Neurol. 2010, 9: 254-263.CrossRefPubMedPubMedCentral van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, Thwaites GE, Tuan PQ, Zwinderman AH: Adjunctive dexamethasone in bacterial meningitis, a meta-analysis of individual patient data. Lancet Neurol. 2010, 9: 254-263.CrossRefPubMedPubMedCentral
Metadata
Title
Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis
Authors
Leonam G Coutinho
Denis Grandgirard
Stephen L Leib
Lucymara F Agnez-Lima
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-326

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.